Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

Calcification associates with transcriptomic signatures related to plaque stability in carotid arteries.

Quillard T.

Atherosclerosis. 2019 Jun 21. pii: S0021-9150(19)31374-7. doi: 10.1016/j.atherosclerosis.2019.06.906. [Epub ahead of print] No abstract available.

PMID:
31280875
2.

Impact of Femoral Ossification on Local and Systemic Cardiovascular Patients' Condition.

Danvin A, Quillard T, Espitia O, Charrier C, Guyomarch B, Gouëffic Y, Maurel B.

Ann Vasc Surg. 2019 Jun 12. pii: S0890-5096(19)30397-8. doi: 10.1016/j.avsg.2019.03.035. [Epub ahead of print]

PMID:
31200045
3.

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.

Marino S, de Ridder D, Bishop RT, Renema N, Ponzetti M, Sophocleous A, Capulli M, Aljeffery A, Carrasco G, Gens MD, Khogeer A, Ralston SH, Gertsch J, Lamoureux F, Heymann D, Rucci N, Idris AI.

EBioMedicine. 2019 Jun;44:452-466. doi: 10.1016/j.ebiom.2019.05.048. Epub 2019 May 29.

4.

French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease.

Alimi Y, Hauguel A, Casbas L, Magnan PE, Pin JL, Sabatier J, Régnard O, Gouëffic Y; French Society of Vascular and Endovascular Surgery (SCVE).

Ann Vasc Surg. 2019 Aug;59:248-258. doi: 10.1016/j.avsg.2019.05.001. Epub 2019 May 25.

PMID:
31132446
5.

Corrigendum to "Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells" [Bone 122 (May 2019) 82-92].

Faraahi Z, Baud'huin M, Croucher PI, Eaton C, Lawson MA.

Bone. 2019 Jul;124:166. doi: 10.1016/j.bone.2019.04.020. Epub 2019 May 2. No abstract available.

6.

Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells.

Faraahi Z, Baud'huin M, Croucher PI, Eaton C, Lawson MA.

Bone. 2019 May;122:82-92. doi: 10.1016/j.bone.2019.02.012. Epub 2019 Feb 15. Erratum in: Bone. 2019 Jul;124:166.

7.

Murine Models of Bone Sarcomas.

Jacques C, Renema N, Ory B, Walkley CR, Grigoriadis AE, Heymann D.

Methods Mol Biol. 2019;1914:331-342. doi: 10.1007/978-1-4939-8997-3_18.

PMID:
30729474
8.

Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ Hybridization.

Moukengue B, Amiaud J, Jacques C, Charrier C, Ory B, Lamoureux F.

Methods Mol Biol. 2019;1914:169-196. doi: 10.1007/978-1-4939-8997-3_9.

PMID:
30729465
9.

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma.

Georges S, Calleja LR, Jacques C, Lavaud M, Moukengue B, Lecanda F, Quillard T, Gabriel MT, Cartron PF, Baud'huin M, Lamoureux F, Heymann D, Ory B.

Oncotarget. 2018 Nov 6;9(87):35726-35741. doi: 10.18632/oncotarget.26284. eCollection 2018 Nov 6.

10.

A de novo 2q37.2 deletion encompassing AGAP1 and SH3BP4 in a patient with autism and intellectual disability.

Pacault M, Nizon M, Pichon O, Vincent M, Le Caignec C, Isidor B.

Eur J Med Genet. 2018 Nov 22. pii: S1769-7212(18)30243-X. doi: 10.1016/j.ejmg.2018.11.020. [Epub ahead of print]

PMID:
30472483
11.

Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.

Verheije R, Kupchik GS, Isidor B, Kroes HY, Lynch SA, Hawkes L, Hempel M, Gelb BD, Ghoumid J, D'Amours G, Chandler K, Dubourg C, Loddo S, Tümer Z, Shaw-Smith C, Nizon M, Shevell M, Van Hoof E, Anyane-Yeboa K, Cerbone G, Clayton-Smith J, Cogné B, Corre P, Corveleyn A, De Borre M, Hjortshøj TD, Fradin M, Gewillig M, Goldmuntz E, Hens G, Lemyre E, Journel H, Kini U, Kortüm F, Le Caignec C, Novelli A, Odent S, Petit F, Revah-Politi A, Stong N, Strom TM, van Binsbergen E; DDD study, Devriendt K, Breckpot J.

Eur J Hum Genet. 2019 Feb;27(2):278-290. doi: 10.1038/s41431-018-0281-5. Epub 2018 Oct 5.

PMID:
30291340
12.

De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.

Reijnders MRF, Miller KA, Alvi M, Goos JAC, Lees MM, de Burca A, Henderson A, Kraus A, Mikat B, de Vries BBA, Isidor B, Kerr B, Marcelis C, Schluth-Bolard C, Deshpande C, Ruivenkamp CAL, Wieczorek D; Deciphering Developmental Disorders Study, Baralle D, Blair EM, Engels H, Lüdecke HJ, Eason J, Santen GWE, Clayton-Smith J, Chandler K, Tatton-Brown K, Payne K, Helbig K, Radtke K, Nugent KM, Cremer K, Strom TM, Bird LM, Sinnema M, Bitner-Glindzicz M, van Dooren MF, Alders M, Koopmans M, Brick L, Kozenko M, Harline ML, Klaassens M, Steinraths M, Cooper NS, Edery P, Yap P, Terhal PA, van der Spek PJ, Lakeman P, Taylor RL, Littlejohn RO, Pfundt R, Mercimek-Andrews S, Stegmann APA, Kant SG, McLean S, Joss S, Swagemakers SMA, Douzgou S, Wall SA, Küry S, Calpena E, Koelling N, McGowan SJ, Twigg SRF, Mathijssen IMJ, Nellaker C, Brunner HG, Wilkie AOM.

Am J Hum Genet. 2018 Jun 7;102(6):1195-1203. doi: 10.1016/j.ajhg.2018.04.014. Epub 2018 May 31.

13.

Oro-dental phenotype in patients with RUNX2 duplication.

Merametdjian L, Prud'Homme T, Le Caignec C, Isidor B, Lopez-Cazaux S.

Eur J Med Genet. 2019 Feb;62(2):85-89. doi: 10.1016/j.ejmg.2018.05.019. Epub 2018 May 29.

PMID:
29852250
14.

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations.

Jacques C, Renema N, Lezot F, Ory B, Walkley CR, Grigoriadis AE, Heymann D.

J Bone Oncol. 2018 Feb 21;12:7-13. doi: 10.1016/j.jbo.2018.02.004. eCollection 2018 Sep. Review.

15.

Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries.

Steenman M, Espitia O, Maurel B, Guyomarch B, Heymann MF, Pistorius MA, Ory B, Heymann D, Houlgatte R, Gouëffic Y, Quillard T.

Sci Rep. 2018 Mar 2;8(1):3940. doi: 10.1038/s41598-018-22292-y.

16.

Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.

Le Nail LR, Brennan M, Rosset P, Deschaseaux F, Piloquet P, Pichon O, Le Caignec C, Crenn V, Layrolle P, Hérault O, De Pinieux G, Trichet V.

Int J Mol Sci. 2018 Mar 1;19(3). pii: E707. doi: 10.3390/ijms19030707.

17.
18.

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification.

Espitia O, Chatelais M, Steenman M, Charrier C, Maurel B, Georges S, Houlgatte R, Verrecchia F, Ory B, Lamoureux F, Heymann D, Gouëffic Y, Quillard T.

PLoS One. 2018 Jan 26;13(1):e0191976. doi: 10.1371/journal.pone.0191976. eCollection 2018.

19.

A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett-like phenotype.

Vuillaume ML, Jeanne M, Xue L, Blesson S, Denommé-Pichon AS, Alirol S, Brulard C, Colin E, Isidor B, Gilbert-Dussardier B, Odent S, Parent P, Donnart A, Redon R, Bézieau S, Rondard P, Laumonnier F, Toutain A.

Ann Neurol. 2018 Feb;83(2):437-439. doi: 10.1002/ana.25155. Epub 2018 Feb 7. No abstract available.

20.

Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.

Chiu ATG, Pei SLC, Mak CCY, Leung GKC, Yu MHC, Lee SL, Vreeburg M, Pfundt R, van der Burgt I, Kleefstra T, Frederic TM, Nambot S, Faivre L, Bruel AL, Rossi M, Isidor B, Küry S, Cogne B, Besnard T, Willems M, Reijnders MRF, Chung BHY.

Clin Genet. 2018 Apr;93(4):880-890. doi: 10.1111/cge.13196. Epub 2018 Feb 13.

PMID:
29240241

Supplemental Content

Loading ...
Support Center